129 related articles for article (PubMed ID: 38938382)
1. Advancements of non-invasive prenatal testing: the role of obstetricians.
Eltabbakh N; Mohasin Y; Jeddy R
Front Med (Lausanne); 2024; 11():1388481. PubMed ID: 38938382
[TBL] [Abstract][Full Text] [Related]
2. Cell free DNA screening for fetal aneuploidy in Ireland: An observational study of outcomes following insufficient fetal fraction.
Creswell L; Doddy F; Manning C; Nazir SF; Lindow SW; Lynch C; O'Gorman N
Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():143-149. PubMed ID: 37797414
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive prenatal testing for aneuploidy: current status and future prospects.
Benn P; Cuckle H; Pergament E
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):15-33. PubMed ID: 23765643
[TBL] [Abstract][Full Text] [Related]
4. Fetal fraction of cell-free DNA in pregnancies after fresh or frozen embryo transfer following assisted reproductive technologies.
Talbot AL; Ambye L; Hartwig TS; Werge L; Sørensen S; Stormlund S; Prætorius L; Jørgensen HL; Pinborg A; Jørgensen FS
Hum Reprod; 2020 Jun; 35(6):1267-1275. PubMed ID: 32539141
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2019; 19(4):1-166. PubMed ID: 30847010
[TBL] [Abstract][Full Text] [Related]
6. Whole genome non-invasive prenatal testing in prenatal screening algorithm: clinical experience from 12,700 pregnancies.
Baranova EE; Sagaydak OV; Galaktionova AM; Kuznetsova ES; Kaplanova MT; Makarova MV; Belenikin MS; Olenev AS; Songolova EN
BMC Pregnancy Childbirth; 2022 Aug; 22(1):633. PubMed ID: 35945516
[TBL] [Abstract][Full Text] [Related]
7. Genetic Counseling and Management: The First Study to Report NIPT Findings in a Romanian Population.
Gug C; Mozos I; Ratiu A; Tudor A; Gorduza EV; Caba L; Gug M; Cojocariu C; Furau C; Furau G; Vaida MA; Stoicanescu D
Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056387
[No Abstract] [Full Text] [Related]
8. Targeted capture enrichment followed by NGS: development and validation of a single comprehensive NIPT for chromosomal aneuploidies, microdeletion syndromes and monogenic diseases.
Koumbaris G; Achilleos A; Nicolaou M; Loizides C; Tsangaras K; Kypri E; Mina P; Sismani C; Velissariou V; Christopoulou G; Constantoulakis P; Manolakos E; Papoulidis I; Stambouli D; Ioannides M; Patsalis P
Mol Cytogenet; 2019; 12():48. PubMed ID: 31832098
[TBL] [Abstract][Full Text] [Related]
9. Patient experience with non-invasive prenatal testing (NIPT) as a primary screen for aneuploidy in the Netherlands.
Kristalijn SA; White K; Eerbeek D; Kostenko E; Grati FR; Bilardo CM
BMC Pregnancy Childbirth; 2022 Oct; 22(1):782. PubMed ID: 36266611
[TBL] [Abstract][Full Text] [Related]
10. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the results of non-invasive prenatal testing (NIPT) in 545 pregnant women in advanced maternal age.
Su JY; Wei YN; Chen HF; Tong JR; Chen Y; Deng L; Huang LL; Zhang LY
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7101-7106. PubMed ID: 37606120
[TBL] [Abstract][Full Text] [Related]
12. Israeli Society of Medical Genetics NIPT Committee Opinion 072013: Non-invasive prenatal testing of cell-free DNA in maternal plasma for detection of fetal aneuploidy.
Michaelson-Cohen R; Gershoni-Baruch R; Sharoni R; Shochat M; Yaron Y; Singer A
Fetal Diagn Ther; 2014; 36(3):242-4. PubMed ID: 25138112
[TBL] [Abstract][Full Text] [Related]
13. Late first-trimester ultrasound findings can alter management after high-risk NIPT result.
Scott F; Smet ME; Elhindi J; Mogra R; Sunderland L; Ferreira A; Menezes M; Meagher S; McLennan A
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):497-503. PubMed ID: 37247395
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
[TBL] [Abstract][Full Text] [Related]
15. Fetal aneuploidy screening by non-invasive prenatal testing of maternal plasma DNA sequencing with "false negative" result due to confined placental mosaicism: A case report.
Li X; Ju D; Shi Y; Li Y; Dong H; Huang J; Zhang Y
Medicine (Baltimore); 2020 Jul; 99(29):e20848. PubMed ID: 32702826
[TBL] [Abstract][Full Text] [Related]
16. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals.
Kater-Kuipers A; Bunnik EM; de Beaufort ID; Galjaard RJH
BMC Pregnancy Childbirth; 2018 Oct; 18(1):409. PubMed ID: 30340550
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.
Dondorp W; de Wert G; Bombard Y; Bianchi DW; Bergmann C; Borry P; Chitty LS; Fellmann F; Forzano F; Hall A; Henneman L; Howard HC; Lucassen A; Ormond K; Peterlin B; Radojkovic D; Rogowski W; Soller M; Tibben A; Tranebjærg L; van El CG; Cornel MC; ;
Eur J Hum Genet; 2015 Nov; 23(11):1438-50. PubMed ID: 25782669
[TBL] [Abstract][Full Text] [Related]
18. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive Prenatal Testing, What Patients Do Not Learn, May Be Due to Lack of Specialist Genetic Training by Gynecologists and Obstetricians?
Liehr T
Front Genet; 2021; 12():682980. PubMed ID: 34220958
[TBL] [Abstract][Full Text] [Related]
20. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis.
Fairbrother G; Burigo J; Sharon T; Song K
J Matern Fetal Neonatal Med; 2016; 29(7):1160-4. PubMed ID: 26000626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
